Upon analyzing TCGA-ovarian cancer dataset via the Gene Set Enrichment Analysis (GSEA) approach, we found a remarkable overlap between high expression profile of FAM46A and cisplatin resistance gene signatures (Figure 2(a)), suggesting that FAM46A might be involved in regulation of ovarian cancer cisplatin resistance. Here, TENT5A is linked to ovarian cancer.